|
RNCOS Releases a New Report- Russian Pharma Sector Analysis
RNCOS has recently added a new Market Research Report titled,
"Russian Pharma Sector Analysis" to its report gallery. According to the
report, the Russian pharmaceutical market grew at a slow pace in 2007
but it still is attractive as compared to previous years that recorded
no-so-impressive performance due to the state segment. In the Russian
pharma market, both the retail segment and parapharmaceutical market
registered double-digit growth in sales value, with parapharmaceutical
recording the highest growth rate and retail segment contributing the
maximum share in sales value terms.
This research report provides an extensive research and objective
analysis on the growing demand of pharmaceuticals in Russia and presents
a clear picture of the country's healthcare and pharmaceutical market.
It covers Russian demographics, structure of healthcare sector, size and
growth of pharmaceutical market, leading drugs, segment-wise break up,
and information on major therapy areas to give strategic insight into
the market. This report briefly discusses the major players operating in
each segment of the market. The share of imported and domestic drugs, RX
and OTC drugs, and sales structure by ATC group has also been analyzed
in context of the Russian pharmaceutical market.
Key Research Findings
- The Russian pharmaceutical market grew 16% in 2007 as compared to
2006.
- State segment grew at a slower rate while the parapharmaceutical and
commercial segments recorded impressive growth rates in 2007.
- In 2007, new drugs segment increased at fast pace as more than 230 new
drug trade names appeared in the Russian pharmaceutical market.
- In 2007, Sanofi-Aventis was the leader of the retail sales among the
drug manufacturers in commercial drug market segment.
- The consumption value provided by the State Reimbursement Program
(DLO) decreased in 2007 due to diminishing requirement.
- The Russian pharmaceutical market is forecasted to grow at a CAGR of
14.36% by 2012.
Key Issues Analyzed in the Report
- Where does the Russian pharmaceutical market stand in comparison to
other key global markets?
- What is the market size of various segments in the Russian
pharmaceutical industry?
- What is the proportion of domestic and imported drugs in each segment?
- What are the opportunities that will emerge in future for the market?
- Who are the major players in the Russian pharmaceutical market?
Research Methodology Used in the Report
Information Sources
The information in this report has been taken from various credible
sources like books, newspapers, trade journals, white papers, industry
portals, government agencies, trade associations, monitoring industry
news and developments, and through access to more than 3000 paid
databases.
Analysis Methods
The analysis methods used in this report include ratio analysis,
historical trend analysis, linear regression analysis using software
tools, judgmental forecasting, and cause and effect analysis.
For the purpose of this report, the Russian pharmaceutical market has
been considered to consist of the following segments:
? Commercial drugs market;
? State segment (DLO programme and Hospital Segment)
? Parapharmaceutical segment (Food Supplements and Cosmetics)
About RNCOS E-Services Pvt Ltd.
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
For more information visit:
http://www.rncos.com/Report/IM548.htm
Current Industry News:
http://www.rncos.com/blog
Would you like to see your news and articles here? GO>>
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.comŽ, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.comŽ or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.comŽ endorsing the content as a recommendation to buy or sell stock.
|
